30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Puissance Life Science Opportunities Fund VI

Track

Insider profile

Performance

Overall performance
3.7
Performance over holding periods
3.7
30 days 90 days 120 days
Average return 91% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
2 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Puissance Life Science Opportunities Fund VI's trades of Bellerophon Therapeutics Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2023-06-07 2023-06-07
PrS Proposed sale
92,783
165.63
US$502,266 		92,783 165.63 US$502,266
2023-06-07 2023-06-07
S Sale
46,695 -36.9%
124.28
US$4,420,056 		46,695 -36.9% 124.28 US$4,420,056
2023-05-19 2023-05-18
S Sale
24,681 +1.7%
422.85
US$3,842,145 		24,681 +1.7% 422.85 US$3,842,145
2023-05-18 2023-05-18
PrS Proposed sale
560,000
9.46
US$5,297,600 		560,000 9.46 US$5,297,600